ARMATA PHARMACEUTICALS INC's ticker is ARMP and the CUSIP is 04216R102. A total of 22 filers reported holding ARMATA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6 | +200.0% | 2 | 0.0% | 0.00% | – |
Q2 2023 | $2 | -33.3% | 2 | 0.0% | 0.00% | – |
Q1 2023 | $3 | -82.4% | 2 | -85.7% | 0.00% | – |
Q4 2022 | $17 | – | 14 | +1300.0% | 0.00% | – |
Q3 2022 | $0 | -100.0% | 1 | -99.9% | 0.00% | – |
Q2 2022 | $4,000 | -20.0% | 1,071 | 0.0% | 0.00% | – |
Q1 2022 | $5,000 | -16.7% | 1,071 | -1.3% | 0.00% | – |
Q4 2021 | $6,000 | +50.0% | 1,085 | -5.1% | 0.00% | – |
Q3 2021 | $4,000 | -50.0% | 1,143 | -42.6% | 0.00% | – |
Q2 2021 | $8,000 | -20.0% | 1,992 | 0.0% | 0.00% | – |
Q1 2021 | $10,000 | +66.7% | 1,992 | 0.0% | 0.00% | – |
Q4 2020 | $6,000 | 0.0% | 1,992 | 0.0% | 0.00% | – |
Q3 2020 | $6,000 | -25.0% | 1,992 | 0.0% | 0.00% | – |
Q2 2020 | $8,000 | +33.3% | 1,992 | 0.0% | 0.00% | – |
Q1 2020 | $6,000 | 0.0% | 1,992 | 0.0% | 0.00% | – |
Q4 2019 | $6,000 | -25.0% | 1,992 | -10.6% | 0.00% | – |
Q3 2019 | $8,000 | +700.0% | 2,227 | +1457.3% | 0.00% | – |
Q2 2019 | $1,000 | – | 143 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SeaCrest Wealth Management, LLC | 13,500 | $65,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 48,400 | $231,000 | 0.00% |
LOOMIS SAYLES & CO L P | 129,956 | $621,000 | 0.00% |
Renaissance Technologies | 123,816 | $592,000 | 0.00% |
ROYAL BANK OF CANADA | 50 | $0 | 0.00% |
VANGUARD GROUP INC | 75,596 | $362,000 | 0.00% |
TCI Wealth Advisors, Inc. | 100 | $0 | 0.00% |
UBS Group AG | 6,017 | $29,000 | 0.00% |
Sowell Financial Services LLC | 109 | $0 | 0.00% |
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 571 | $3,000 | 0.00% |